Sexually Transmitted Infections

April 26th 2024

Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.

April 15th 2024

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

April 11th 2024

In a recent interview, Cheruba Prabakar, MD, FACOG, shed light on the rising prevalence of sexually transmitted infections in the United States and the need for improved awareness and testing, particularly for overlooked conditions such as trichomoniasis.

March 11th 2024

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.